[PPB] YoY Cumulative Quarter Result on 30-Sep-2016 [#3]

Stock
[PPB] PPB GROUP BHD
Announcement Date
23-Nov-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
30-Sep-2016 [#3]
Profit Trend
QoQ- 227.7%
YoY- -22.71%
Quarter Report
Latest QR
Upcoming QR
PPB's Result
PPB's Financial Summary
View:
Show?
Cumulative Result
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Revenue 3,503,068 3,364,047 3,168,243 3,162,931 2,957,714 2,767,794 2,412,730 6.40%
PBT 883,021 920,964 903,911 684,285 802,374 732,217 748,148 2.79%
Tax -49,829 -53,488 -45,437 -82,824 -81,694 -74,142 -36,914 5.12%
NP 833,192 867,476 858,474 601,461 720,680 658,075 711,234 2.67%
-
NP to SH 802,606 853,757 829,522 548,965 710,290 635,345 701,881 2.25%
-
Tax Rate 5.64% 5.81% 5.03% 12.10% 10.18% 10.13% 4.93% -
Total Cost 2,669,876 2,496,571 2,309,769 2,561,470 2,237,034 2,109,719 1,701,496 7.79%
-
Net Worth 21,310,545 20,869,540 21,078,188 19,501,473 20,046,802 15,826,423 15,280,550 5.69%
Dividend
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Div 113,807 113,807 94,839 94,839 94,839 82,984 94,836 3.08%
Div Payout % 14.18% 13.33% 11.43% 17.28% 13.35% 13.06% 13.51% -
Equity
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Net Worth 21,310,545 20,869,540 21,078,188 19,501,473 20,046,802 15,826,423 15,280,550 5.69%
NOSH 1,422,599 1,422,599 1,185,499 1,185,499 1,185,499 1,185,499 1,185,457 3.08%
Ratio Analysis
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
NP Margin 23.78% 25.79% 27.10% 19.02% 24.37% 23.78% 29.48% -
ROE 3.77% 4.09% 3.94% 2.81% 3.54% 4.01% 4.59% -
Per Share
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
RPS 246.24 236.47 267.25 266.80 249.49 233.47 203.53 3.22%
EPS 56.42 60.01 69.97 46.31 59.91 53.59 59.21 -0.80%
DPS 8.00 8.00 8.00 8.00 8.00 7.00 8.00 0.00%
NAPS 14.98 14.67 17.78 16.45 16.91 13.35 12.89 2.53%
Adjusted Per Share Value based on latest NOSH - 1,185,499
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
RPS 246.25 236.48 222.71 222.34 207.92 194.56 169.61 6.40%
EPS 56.42 60.02 58.31 38.59 49.93 44.66 49.34 2.25%
DPS 8.00 8.00 6.67 6.67 6.67 5.83 6.67 3.07%
NAPS 14.9805 14.6704 14.8171 13.7088 14.0921 11.1253 10.7416 5.69%
Price Multiplier on Financial Quarter End Date
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Date 30/09/19 28/09/18 29/09/17 30/09/16 30/09/15 30/09/14 30/09/13 -
Price 18.14 16.78 16.86 16.18 15.42 14.20 14.22 -
P/RPS 7.37 7.10 6.31 6.06 6.18 6.08 6.99 0.88%
P/EPS 32.15 27.96 24.10 34.94 25.74 26.50 24.02 4.97%
EY 3.11 3.58 4.15 2.86 3.89 3.77 4.16 -4.73%
DY 0.44 0.48 0.47 0.49 0.52 0.49 0.56 -3.93%
P/NAPS 1.21 1.14 0.95 0.98 0.91 1.06 1.10 1.60%
Price Multiplier on Announcement Date
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Date 21/11/19 27/11/18 23/11/17 23/11/16 26/11/15 26/11/14 25/11/13 -
Price 18.24 17.00 16.76 15.76 15.62 15.50 14.60 -
P/RPS 7.41 7.19 6.27 5.91 6.26 6.64 7.17 0.55%
P/EPS 32.33 28.33 23.95 34.03 26.07 28.92 24.66 4.61%
EY 3.09 3.53 4.17 2.94 3.84 3.46 4.06 -4.44%
DY 0.44 0.47 0.48 0.51 0.51 0.45 0.55 -3.64%
P/NAPS 1.22 1.16 0.94 0.96 0.92 1.16 1.13 1.28%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment